Xu Hou

3.4k total citations
67 papers, 2.3k citations indexed

About

Xu Hou is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Xu Hou has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 17 papers in Physiology and 17 papers in Cancer Research. Recurrent topics in Xu Hou's work include Cancer-related molecular mechanisms research (12 papers), Alzheimer's disease research and treatments (12 papers) and Autophagy in Disease and Therapy (11 papers). Xu Hou is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Alzheimer's disease research and treatments (12 papers) and Autophagy in Disease and Therapy (11 papers). Xu Hou collaborates with scholars based in China, United States and Australia. Xu Hou's co-authors include Fabienne C. Fiesel, Wolfdieter Springer, David H. Small, Jens O. Watzlawik, Marie‐Isabel Aguilar, Dominika Truban, Thomas R. Caulfield, Huailei Liu, Shiguang Zhao and Yaohua Liu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xu Hou

64 papers receiving 2.3k citations

Peers

Xu Hou

PHYSI

EPIDE

CMN

Caoimhín G. Concannon Ireland

Subhas C. Biswas India

Xiaopin Ma United States

Stavit Drori Israel

Zhou Zhu China

Adrian Israelson Israel

Ju Gao China

José M. Lizcano Spain

Vanessa A. Morais Portugal

Quanhong Ma China

Caoimhín G. Concannon Ireland

Xu Hou

2.1k ×1.6

372 ×0.7

PHYSI

345 ×0.8

417 ×1.1

EPIDE

351 ×1.1

CMN

Citations per year, relative to Xu Hou Xu Hou (= 1×) peers Caoimhín G. Concannon

Countries citing papers authored by Xu Hou

Since Specialization

Citations

This map shows the geographic impact of Xu Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Hou more than expected).

Fields of papers citing papers by Xu Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Hou. The network helps show where Xu Hou may publish in the future.

Co-authorship network of co-authors of Xu Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Hou. A scholar is included among the top collaborators of Xu Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Hou. Xu Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Xu, Xiaohong Jiang, Wei Zhang, & Jun Liu. (2025). Bibliometric analysis of nanomaterials in hepatocellular carcinoma treatment: research trends, knowledge structures, and emerging insights (2000–2024). Discover Oncology. 16(1). 213–213.

Naddaf, Elie, Thi Kim Oanh Nguyen, Jens O. Watzlawik, et al.. (2024). NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13672–e13672. 7 indexed citations

Watzlawik, Jens O., Xu Hou, Dominika Fričová, et al.. (2020). Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 17(9). 2613–2628. 35 indexed citations

Wang, Xinzhuang, Ming Gao, Junyi Ye, et al.. (2020). An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis. Frontiers in Genetics. 11. 612037–612037. 26 indexed citations

Hou, Xu, Jens O. Watzlawik, Fabienne C. Fiesel, & Wolfdieter Springer. (2020). Autophagy in Parkinson's Disease. Journal of Molecular Biology. 432(8). 2651–2672. 251 indexed citations

Hou, Xu, Le Yang, Xiaohong Jiang, et al.. (2019). Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. International Journal of Biological Macromolecules. 128. 331–339. 36 indexed citations

Hou, Xu, Samuel O. Adeosun, Xueying Zhao, et al.. (2018). ERβ agonist alters RNA splicing factor expression and has a longer window of antidepressant effectiveness than estradiol after long-term ovariectomy. Journal of Psychiatry and Neuroscience. 44(1). 19–31. 3 indexed citations

Chi, Jingwei, Jing Li, Wei Zhang, et al.. (2017). A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family. PLoS ONE. 12(12). e0189316–e0189316. 9 indexed citations

Truban, Dominika, Xu Hou, Thomas R. Caulfield, Fabienne C. Fiesel, & Wolfdieter Springer. (2016). PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson’s Disease Pathobiology?. Journal of Parkinson s Disease. 7(1). 13–29. 176 indexed citations

10.

Bi, Yunke, Chen Shen, Chenguang Li, et al.. (2015). Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells. Tumor Biology. 37(3). 3549–3560. 52 indexed citations

11.

Sun, Lihua, Xueling Hu, Hui Che, et al.. (2015). MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Navβ2 protein coding region in rat with chronic brain hypoperfusion. Molecular Neurodegeneration. 10(1). 36–36. 19 indexed citations

12.

Hou, Xu, Ying Zhang, & Haiquan Qiao. (2015). CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway. Tumor Biology. 37(1). 641–651. 19 indexed citations

13.

Liu, Huailei, Weiguang Zhang, Kaikai Wang, et al.. (2014). Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS/autophagy. Toxicology Letters. 232(2). 349–355. 48 indexed citations

14.

Adeosun, Samuel O., Xu Hou, Baoying Zheng, et al.. (2013). Cognitive Deficits and Disruption of Neurogenesis in a Mouse Model of Apolipoprotein E4 Domain Interaction. Journal of Biological Chemistry. 289(5). 2946–2959. 39 indexed citations

15.

Wang, Jun Ming, Xu Hou, Samuel O. Adeosun, et al.. (2012). A Dominant Negative ERβ Splice Variant Determines the Effectiveness of Early or Late Estrogen Therapy after Ovariectomy in Rats. PLoS ONE. 7(3). e33493–e33493. 32 indexed citations

16.

Gasperini, Robert, et al.. (2012). Mechanisms of Transthyretin Aggregation and Toxicity. Sub-cellular biochemistry. 65. 211–224. 11 indexed citations

17.

Gómez-Sánchez, Celso E., et al.. (2011). Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids. 76(14). 1541–1545. 23 indexed citations

18.

Gasperini, Robert, Xu Hou, Helena C. Parkington, et al.. (2011). TRPM8 and Nav1.8 sodium channels are required for transthyretin-induced calcium influx in growth cones of small-diameter TrkA-positive sensory neurons. Molecular Neurodegeneration. 6(1). 19–19. 24 indexed citations

19.

Hou, Xu, Ádám Mechler, Lisandra L. Martin, Marie‐Isabel Aguilar, & David H. Small. (2007). Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(1). 198–205. 28 indexed citations

20.

Small, David H., Danuta Maksel, Xu Hou, et al.. (2007). The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor. Journal of Neurochemistry. 101(6). 1527–1538. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact